Thursday, December 12, 2024

Clevira, an antiviral formulation received Government of India regulatory approval as a supportive treatment for mild to moderate COVID-19 cases.

Apex Laboratories Private Limited, a Chennai-based pharmaceutical company known for its cutting-edge research and innovation, introduces Clevira, an antiviral herbal formulation.

Besides, on treatment with Clevira, 86% of patients turned out to be COVID19 RT-PCR test negative on day 5 and 100% of patients turned out to be COVID19 RT-PCR test negative on day 10. Clinical improvement of signs and symptoms of COVID19 was achieved in 4.1 days.  

Underlining how supportive treatment can take the pressure off the already overwhelmed healthcare system, Ms.Subashini Vanangamudi the Executive Director, Apex laboratories Pvt Ltd said “ Along with CAB, supportive treatment can also help in reducing the need for hospitalization among patients suffering from mild to moderate Covid-19 significantly. Even one patient less in the ICU means a lot during this crisis, this would ensure better allotment of resources and medical attention for the needy. It is our duty to join hands in this fight against COVID-19.

Explaining the benefits and uses of Clevira, Mr C Arthur Paul, Manager International Business, Apex Laboratories, said, “The Antiviral drug increases the WBC, Platelet and Lymphocyte counts significantly within the normal range apart from reducing the Viral load, hence the recovery from all signs and symptoms is much faster. Significant reduction in Erythrocyte Sedimentation Rate (ESR) is evident that the drug elicits anti-inflammatory property.

Clevira is proven effective as an Analgesic, Antipyretic and reversal of thrombocytopenia. It is absolutely safe for people with liver or kidney ailments and can be safely co-administered with other drugs.

On the availability of the drug, Mr. Karthik  Shanmugam, Head of Marketing, Apex Laboratories Pvt Ltd, said, “The drug is already available in the market across India. Moreover, it would not only compliment the allopathic treatment but also reduce the huge socioeconomic burden the country is facing now, by improving the recovery rates. We have also priced the drug affordable so that it reaches everyone in society. Each tablet of Clevira costs only Rs. 11/-.

Clevira is effective when taken orally and the dosage is one tablet twice daily after food for 14 days.  It has also proved to be safe on Liver and Kidney parameters.

Recent Articles

Related Stories

Leave A Reply

Please enter your comment!
Please enter your name here

Stay on op - Ge the daily news in your inbox